down arrow

Ono Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3197600004
JPY
2,178.50
14 (0.65%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Astellas Pharma, Inc.
Chugai Pharmaceutical Co., Ltd.
Shionogi & Co., Ltd.
Otsuka Holdings Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.
Eisai Co., Ltd.
Kyowa Kirin Co., Ltd.
Takeda Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd.
Why is Ono Pharmaceutical Co., Ltd. ?
1
High Management Efficiency with a high ROE of 12.49%
2
Company has very low debt and has enough cash to service the debt requirements
3
The company has declared Negative results for the last 3 consecutive quarters
  • NET PROFIT(HY) At JPY 11,044 MM has Grown at -73.85%
  • INTEREST(HY) At JPY 3,232 MM has Grown at 4,209.33%
  • OPERATING CASH FLOW(Y) Lowest at JPY 85,019 MM
4
With ROE of 6.41%, it has a very attractive valuation with a 0.97 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 26.62%, its profits have fallen by -62%
  • At the current price, the company has a high dividend yield of 0
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Ono Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Ono Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Ono Pharmaceutical Co., Ltd.
26.62%
-0.12
26.26%
Japan Nikkei 225
28.54%
1.11
25.75%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.73%
EBIT Growth (5y)
-4.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.57
Tax Ratio
15.48%
Dividend Payout Ratio
75.08%
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
20.45%
ROE (avg)
12.49%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.97
EV to EBIT
10.81
EV to EBITDA
7.59
EV to Capital Employed
0.96
EV to Sales
1.41
PEG Ratio
NA
Dividend Yield
0.03%
ROCE (Latest)
8.91%
ROE (Latest)
6.41%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-22What is not working for the Company
NET PROFIT(HY)

At JPY 11,044 MM has Grown at -73.85%

INTEREST(HY)

At JPY 3,232 MM has Grown at 4,209.33%

OPERATING CASH FLOW(Y)

Lowest at JPY 85,019 MM

ROCE(HY)

Lowest at 5.41%

RAW MATERIAL COST(Y)

Grown by 5.16% (YoY

PRE-TAX PROFIT(Q)

Fallen at -32%

Here's what is working for Ono Pharmaceutical Co., Ltd.
Depreciation
Highest at JPY 9,238 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Ono Pharmaceutical Co., Ltd.
Net Profit
At JPY 11,044 MM has Grown at -73.85%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Interest
At JPY 3,232 MM has Grown at 4,209.33%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Operating Cash Flow
Lowest at JPY 85,019 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (JPY MM)

Pre-Tax Profit
Fallen at -32%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Raw Material Cost
Grown by 5.16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."